Clinical Trials Logo

Adherence, Medication clinical trials

View clinical trials related to Adherence, Medication.

Filter by:
  • Not yet recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06233123 Not yet recruiting - Bronchial Asthma Clinical Trials

Efficacy of a Phone Application on Treatment Adherence in Asthmatic Patients in Upper Egypt

Start date: February 1, 2024
Phase: N/A
Study type: Interventional

asthma adherence is mandatory for disease control

NCT ID: NCT06200623 Not yet recruiting - Bronchial Asthma Clinical Trials

Cognitive and Emotional Factors Relation to Treatment Adherence in Asthmatic Patients in Upper Egypt

Start date: January 1, 2024
Phase:
Study type: Observational

Non-adherence to controller therapy is one of the main reasons of poor asthma control. Adherence to medication in different studies range between 30 and 70% . Several factors related to the disease, to the patient, treatment or physician- patient relationship

NCT ID: NCT06182280 Not yet recruiting - HIV Infections Clinical Trials

Transmaculine One-on-One and Group Empowerment for Targeted HIV Reduction

TOGETHR
Start date: January 2024
Phase: N/A
Study type: Interventional

Transgender masculine and gender diverse people who have sex with men (TMSM) have an increased risk of HIV and face unique barriers engaging in prevention services. Digitally delivered support interventions addressing HIV prevention barriers delivered by peers in one-on-one or small-group settings may be effective at increasing PrEP engagement. This study examines the independent and combined effects of individual and group-based peer-support interventions on PrEP outcomes. Participants will be randomly assigned to receive: (i) standard-of-care HIV prevention information, (ii) a one-on-one healthy lifestyle intervention tailored for transgender masculine people, (iii) a peer-group based healthy lifestyle intervention for transgender masculine people, or (iv) both the one-on-one and group-based interventions delivered together. The hypotheses are that the individual group-based interventions will result in higher PrEP uptake and persistence than the standard of care and that the combined interventions will be more effective than receiving one individual intervention.

NCT ID: NCT06056037 Not yet recruiting - Hiv Clinical Trials

Making ART Work Among Brazilian Youth

Start date: October 1, 2023
Phase: N/A
Study type: Interventional

This study seeks to develop and pilot test a theory-based, integrated technology and counseling intervention to improve ART adherence among sexual and gender minority (SGM) young people living with HIV (ages 18-24) in Rio de Janeiro, Brazil. The intervention aims to improve social support, self-efficacy for taking ART, and teach skills for problem-solving barriers to promote better adherence.

NCT ID: NCT05998876 Not yet recruiting - Opioid Use Disorder Clinical Trials

Assessing Dose Taken in Opioid Use Disordered Patients With an Electrochemical Sensor

Start date: February 2024
Phase:
Study type: Observational

CARI Health aims to develop a methadone dose taken sensor that provides real-time data on interstitial fluid (ISF) levels that could be used as a methadone adherence monitor for daily doses. Use of such a monitor would allow for the physician, counselor, patient, and family member to remotely verify that a physician prescribed dose has been taken. Such a verification system can allow methadone clinics greater flexibility in the provision of take-home doses and thus retain more patients in the clinic.

NCT ID: NCT05997914 Not yet recruiting - Stroke Clinical Trials

Storytelling for Reducing Gap in Anticoagulation Use in African Americans With Atrial Fibrillation

Start date: May 2024
Phase: N/A
Study type: Interventional

The overall goal of this study is to evaluate the effectiveness of a previously developed storytelling intervention on anticoagulation (AC) initiation/persistence in African American and Black patients with atrial fibrillation/flutter. The investigators hope to gain knowledge that may help treat atrial fibrillation or flutter and lower stroke and adverse cardiovascular event risks for African American and Black patients by increasing the use of blood thinning medications known as anticoagulants.

NCT ID: NCT05909891 Not yet recruiting - Fatigue Clinical Trials

Treatment Adherence and Fatigue in Iron Deficiency

Start date: July 1, 2023
Phase: N/A
Study type: Interventional

Iron Deficiency Anemia is an important health problem. Iron deficiency anemia constitutes half of the anemia seen in the world, and children and women constitute the group with iron deficiency anemia in our country (Internal Medicine Nursing Book with Case Scenarios, 2019; Turkey Program Guide as Iron). The treatment is iron replacement by oral or parenteral route (Guzelcuk, Ozbek, 2017). Due to the side effects of the drugs given in the treatment, the patients have difficulty in adapting to the treatment and there is a change in their fatigue levels (Guzelcuk, Özbek, 2017; Guide, 2019; Çipil, Demircioğlu, 2016). It is thought that the education given to the patients will increase their compliance with the treatment. It is thought that patients' hospital admissions and fatigue levels may change in the failure to comply with the treatment. In this study, the effect of the education given on the treatment compliance and fatigue of the patients will be investigated. This research will help patients with iron deficiency anemia whether they need education, the importance of treatment compliance and their fatigue levels.

NCT ID: NCT05286216 Not yet recruiting - Quality of Life Clinical Trials

The Effect of Education on Drug Compliance and Quality of Life in Hepatitis B Patients

Start date: April 15, 2022
Phase: N/A
Study type: Interventional

The aim of this study is to determine the effect of the education given to patients with CHB who use oral antiviral drugs on oral antiviral drug use on drug compliance and quality of life.

NCT ID: NCT05207449 Not yet recruiting - Quality of Life Clinical Trials

Health Challenges for Adolescents With Chronic Diseases in Egypt

Start date: March 1, 2022
Phase:
Study type: Observational

The World Health Organization (WHO) defines adolescents as those people between 10 and 19 years of age. Adolescence is a critical developmental stage especially in the context of living with a chronic disease (CD), a chronic disease can be defined as "physiological, behavioral or cognitive disorder that has lasted for one year and produces one or more types of consequences: functional constraints, dependency on compensatory assistance for functioning, or increased need of service compared with age-mates". The burden of chronic conditions in adolescence is increasing as larger numbers of chronically ill children survive beyond the age of 10. Over 85% of children with congenital or chronic conditions now survive into adolescence, and conditions once seen only in young children are now seen beyond childhood and adolescence.

NCT ID: NCT04550533 Not yet recruiting - Clinical trials for Adherence, Medication

DESIGN OF A SCALE TO MEASURE COMPLIANCE WITH DRUG TREATMENT IN PATIENTS WITH ORAL CHEMOTHERAPY

Start date: January 2021
Phase:
Study type: Observational

Introduction: In recent years, there has been an increase in the use of oral chemotherapy, for its comfort and for allowing a higher quality of life. However, one of the main drawbacks is the lack of adherence to treatment with important clinical, social and economic consequences. In this scenario, the investigators did not have a questionnaire designed and validated to measure adherence in onco-hematological patients, a population that was erroneously considered very adherent. The objective of the investigators is to build and validate a questionnaire to measure adherence to treatment in oncohematological patients in treatment with oral anti-cancer drugs. Methods and analysis: An observational study to validate questionnaires will be carried out combining qualitative and quantitative research techniques. With the results of a systematic review of the literature and a qualitative study based on focus groups, a questionnaire will be designed to measure adherence in oncohematological patients in treatment with with oral anti-cancer drugs. The investigators will include patiens from two hospitals in the Valencian Community. Discussion: It is essential to have a simple, reliable and validated instrument for measuring adherence in cancer patients undergoing treatment with oral antineoplastic agents. With this, lack of therapeutic compliance and its causes can be detected in order to establish interventions that improve it.